Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 13463-41-7 Chemical Structure| 13463-41-7

Structure of Zinc pyrithione
CAS No.: 13463-41-7

Chemical Structure| 13463-41-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zinc pyrithione is proton pump blocker which disrupts membrane transport and can be used as antifungal and antibacterial agent.

Synonyms: OM-1563

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zinc pyrithione

CAS No. :13463-41-7
Formula : C10H8N2O2S2Zn
M.W : 317.72
SMILES Code : [O-][N+]1=C(C=CC=C1)S[Zn]SC2=[N+]([O-])C=CC=C2
Synonyms :
OM-1563
MDL No. :MFCD00067336
InChI Key :OTPSWLRZXRHDNX-UHFFFAOYSA-L
Pubchem ID :26041

Safety of Zinc pyrithione

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H318-H410
Precautionary Statements:P273-P280-P301+P310-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Description
Zinc Pyrithione is an antifungal and antibacterial agent by disrupting membrane transport through blocking the proton pump[1].
Target
  • Proton Pump

In Vitro:

Cell Line
Concentration Treated Time Description References
Human lung tissue (HLT) cells 30, 10, 1, 0.5 µM 1 hour Evaluation of zinc pyrithione's inhibitory effect on SARS-CoV-2 entry, showing 93.12% inhibition at 30 μM concentration. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2158-2168.
DRG neurons 1 µM 20 seconds ZnPy induces Ca2+ responses via TRPA1 Proc Natl Acad Sci U S A. 2009 May 19;106(20):8374-9.
T98GN cancer cells 10 µM 2 hours Measured intracellular zinc levels, showing ZP significantly increased intracellular Zn Cell Syst. 2017 Jun 28;4(6):600-610.e6.
A549N cancer cells 10 µM 2 hours Measured intracellular zinc levels, showing ZP significantly increased intracellular Zn Cell Syst. 2017 Jun 28;4(6):600-610.e6.
Streptococcus dysgalactiae 0.031 µg/mL 24 hours Evaluate the synergistic antibacterial effect of zinc pyrithione with gentamicin, showing strong synergy Antibiotics (Basel). 2022 Jul 17;11(7):960.
Streptococcus agalactiae 0.031 µg/mL 24 hours Evaluate the synergistic antibacterial effect of zinc pyrithione with gentamicin, showing strong synergy Antibiotics (Basel). 2022 Jul 17;11(7):960.
Staphylococcus aureus 0.25 µg/mL 24 hours Evaluate the synergistic antibacterial effect of zinc pyrithione with gentamicin, showing high susceptibility in some strains Antibiotics (Basel). 2022 Jul 17;11(7):960.
HSC2 cells 0.5 µM to 2 µM 48 hours PYZ treatment led to 52.7% cells in sub-G0 phase and significantly increased apoptosis (from 21.6% to 88.8%). Mol Oncol. 2015 Oct;9(8):1720-35.
MDA1986 cells 0.5 µM to 2 µM 48 hours PYZ treatment resulted in 85.7% cells in sub-G0 phase and markedly induced apoptosis (increased from 16.9% to 93.6%). Mol Oncol. 2015 Oct;9(8):1720-35.
SCC4 cells 0.5 µM to 2 µM 48 hours PYZ treatment induced cell cycle arrest and apoptosis, significantly increasing sub-G0 fraction (65.6%) and activating cleavage of caspase 3, caspase 9, and PARP. Mol Oncol. 2015 Oct;9(8):1720-35.
M10 cells 0.5 µM 72 hours To evaluate the effect of zinc pyrithione on the proliferation, intracellular free zinc content, and autophagic activity of M10 cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels, inhibited cell proliferation, and enhanced autophagic activity over 72 hours. Int J Mol Sci. 2021 Jan 11;22(2):667.
M9 cells 0.5 µM 72 hours To evaluate the effect of zinc pyrithione on the proliferation, intracellular free zinc content, and autophagic activity of M9 cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels, strongly inhibited cell proliferation, and significantly enhanced autophagic activity over 72 hours. Int J Mol Sci. 2021 Jan 11;22(2):667.
M5 cells 0.5 µM 72 hours To evaluate the effect of zinc pyrithione on the proliferation, intracellular free zinc content, and autophagic activity of M5 cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels, inhibited cell proliferation, and enhanced autophagic activity over 72 hours. Int J Mol Sci. 2021 Jan 11;22(2):667.
HEM cells 0.5 µM 72 hours To evaluate the effect of zinc pyrithione on the proliferation and intracellular free zinc content of HEM cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels but had a weaker inhibitory effect on cell proliferation over 72 hours. Int J Mol Sci. 2021 Jan 11;22(2):667.
Bowes cells 0.5 µM 72 hours To evaluate the effect of zinc pyrithione on the proliferation and intracellular free zinc content of Bowes cells. Results showed that 0.5 µM zinc pyrithione significantly increased intracellular free zinc levels and inhibited cell proliferation over 72 hours. Int J Mol Sci. 2021 Jan 11;22(2):667.
FHs 74 Int (normal intestinal cells) 0.3 µg/mL 72 hours Evaluate the cytotoxicity of zinc pyrithione on normal intestinal cells, showing some toxicity to normal cells. Pharmaceuticals (Basel). 2020 Sep 3;13(9):233.
Caco-2 (intestinal cancer cells) 0.7 µg/mL 72 hours Evaluate the antiproliferative activity of zinc pyrithione on Caco-2 intestinal cancer cells, showing significant cytotoxicity. Pharmaceuticals (Basel). 2020 Sep 3;13(9):233.
HT29 (intestinal cancer cells) 0.6 µg/mL 72 hours Evaluate the antiproliferative activity of zinc pyrithione on HT29 intestinal cancer cells, showing significant cytotoxicity. Pharmaceuticals (Basel). 2020 Sep 3;13(9):233.
CHO cells 2.4 µM (EC50) ZnPy activates TRPA1 by increasing intracellular Zn2+ concentration Proc Natl Acad Sci U S A. 2009 May 19;106(20):8374-9.
CHO cells 10 µM Study the effect of ZnPy on KCNQ3 channels, showing no response to ZnPy. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3128-33.
CHO cells 10 µM Investigate the potentiating effect of ZnPy on KCNQ2 channels, showing significant increase in current amplitude. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3128-33.
Hippocampal neurons 10 µM To study the inhibitory effect of ZnPy on neuronal firing after muscarinic receptor activation. Results showed that ZnPy completely abolished Oxo-M-induced spontaneous firing, whereas retigabine only partially inhibited it. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8726-31.
CHO cells 10 µM To investigate the augmentation effect of ZnPy on KCNQ2 currents after M1 receptor activation. Results showed that ZnPy immediately augmented the Oxo-M suppressed KCNQ2 current, and the effect was reversible. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8726-31.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOD/SCID/Crl mice SCC4 xenograft model Intraperitoneal injection 1 mg/kg Weekly for 6 weeks PYZ treatment significantly reduced tumor volume (mean 316.24 mm3 vs control 479.6 mm3) without apparent toxicity. β-catenin expression decreased (positive cells reduced from 67% to 8%). Mol Oncol. 2015 Oct;9(8):1720-35.
Drosophila melanogaster GNAO1 encephalopathy model Dietary supplementation 10 µM Continuous supplementation starting from the egg stage To test the effect of dietary zinc supplementation on the motor function and lifespan of Drosophila, results showed that ZnCl2 significantly improved the motor function and lifespan of mutant flies. Sci Adv. 2022 Oct 7;8(40):eabn9350
Human skin Human abdominal skin Topical application 2% w/v 24 hours To assess the delivery and dissolution of zinc pyrithione in hair follicles Pharmaceutics. 2022 May 17;14(5):1076
Mice TRPA1-deficient mice Intraplantar injection 2.5 nmoles Single injection, observed for 4 hours CQ induces mechanical hyperalgesia and cold hypersensitivity via TRPA1 Proc Natl Acad Sci U S A. 2009 May 19;106(20):8374-9.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.15mL

0.63mL

0.31mL

15.74mL

3.15mL

1.57mL

31.47mL

6.29mL

3.15mL

References

 

Historical Records

Categories